(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a presentation by Dr. Robert Dess discussing the prognostic and predictive performance of routine clinicopathologic variables in men enrolled in phase III randomized clinical trials in localized prostate cancer.